KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Short-term Investments (2016 - 2025)

Johnson & Johnson's Short-term Investments history spans 17 years, with the latest figure at $393.0 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 5.76% year-over-year to $393.0 million; the TTM value through Dec 2025 reached $393.0 million, down 5.76%, while the annual FY2025 figure was $393.0 million, 5.76% down from the prior year.
  • Short-term Investments for Q4 2025 was $393.0 million at Johnson & Johnson, up from $331.0 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $22.7 billion in Q4 2022 and bottomed at $317.0 million in Q3 2024.
  • The 5-year median for Short-term Investments is $7.3 billion (2023), against an average of $7.6 billion.
  • The largest annual shift saw Short-term Investments surged 465.09% in 2021 before it crashed 88.63% in 2023.
  • A 5-year view of Short-term Investments shows it stood at $13.4 billion in 2021, then surged by 69.62% to $22.7 billion in 2022, then tumbled by 95.3% to $1.1 billion in 2023, then crashed by 60.96% to $417.0 million in 2024, then fell by 5.76% to $393.0 million in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Short-term Investments are $393.0 million (Q4 2025), $331.0 million (Q3 2025), and $417.0 million (Q4 2024).